Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
5 Years Aggregate
CFO
$241.33 Mln
EBITDA
$92.73 Mln
Net Profit
$115.01 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Cellebrite DI Ltd. Warrants (CLBTW)
| 234.3 | 18.7 | 81.6 | 368.6 | 27.5 | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
Company
|
2023
|
2022
|
|---|---|---|
|
Cellebrite DI Ltd. Warrants (CLBTW)
| 154.0 | -64.9 |
|
BSE Sensex
| 18.7 | 4.4 |
|
BSE Sensex
| 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Cellebrite DI Ltd. Warrants (CLBTW)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data... across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel. Read more
-
Founder, CEO & Director
Mr. Yossi Carmil
-
Founder, CEO & Director
Mr. Yossi Carmil
-
Headquarters
Petah Tikva
-
Website
FAQs for Cellebrite DI Ltd. Warrants (CLBTW)
What is the current share price of Cellebrite DI Ltd Warrants (CLBTW) Today?
The share price of Cellebrite DI Ltd Warrants (CLBTW) is $5.25 (NASDAQ) as of 16-Sep-2024 16:00 EDT. Cellebrite DI Ltd Warrants (CLBTW) has given a return of 27.54% in the last 3 years.
What is the current PB & PE ratio of Cellebrite DI Ltd Warrants (CLBTW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-3.81 |
9.03 |
2022 |
0.97 |
1.59 |
2021 |
4.91 |
-4.78 |
2020 |
-- |
-- |
2019 |
-- |
-- |
What is the 52 Week High and Low of Cellebrite DI Ltd Warrants (CLBTW)?
The 52-week high and low of Cellebrite DI Ltd Warrants (CLBTW) are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of Cellebrite DI Ltd Warrants (CLBTW)?
Cellebrite DI Ltd Warrants (CLBTW) has a market capitalisation of -- as on 16-Sep-2024. As per SEBI classification, it is a company.
Should I invest in Cellebrite DI Ltd Warrants (CLBTW)?
Before investing in Cellebrite DI Ltd Warrants (CLBTW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.